dr. coleman on rationale for using veliparib and chemotherapy in ovarian cancer
Published 4 years ago • 111 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:12
dr. coleman on the use of veliparib in advanced ovarian cancer
-
1:55
rationale for chemotherapy plus veliparib in frontline treatment of ovarian cancers
-
1:12
dr. coleman on next treatment steps for patients with ovarian cancer
-
2:03
dr. coleman on results of the velia trial in ovarian cancer
-
1:13
dr. coleman on implications of the velia trial in ovarian cancer
-
5:40
combination veliparib and chemotherapy in ovarian cancer
-
3:29
dr. coleman on advances made in ovarian cancer treatment
-
0:16
copy of dr. coleman on classifying patients with ovarian cancer
-
1:59
dr. coleman on next steps following ariel2 trial for ovarian cancer
-
1:04
dr. coleman on the velia trial impact on ovarian cancer practice
-
1:25
robert l. coleman, md, facog, facs, on how veliparib factors into ovarian cancer treatment
-
1:13
dr. coleman on recent advances and remaining questions in ovarian cancer
-
1:35
dr. coleman on immunotherapy in ovarian cancer
-
1:14
dr. coleman on classifying patients with ovarian cancer
-
1:14
dr. coleman on benefit of rucaparib in ovarian cancer
-
26:02
updates in ovarian cancer: frontline maintenance
-
2:22
dr. robert coleman on the importance of brca testing in ovarian cancer
-
1:47
dr. o’malley on antitumor activity with veliparib combo in serous ovarian cancer
-
1:48
dr. penson on olaparib monotherapy vs chemo for ovarian cancer